Clinical Trial Update: Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating safety and pharmacokinetics of Alpha-1 MP (modified process human alpha1-proteinase inhibitor) in individuals with Alpha-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) (Alpha-1 MP)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Alpha1-Antitrypsin Deficiency | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-18